Opportunity
Federal Register #0920-1193
CDC Evaluation of Training and Technical Assistance Programs for Cancer Control
Buyer
Centers for Disease Control and Prevention
Posted
August 20, 2026
Identifier
0920-1193
NAICS
541720
This opportunity involves the Centers for Disease Control and Prevention (CDC) evaluating its Training and Technical Assistance (TTA) Programs for the National Comprehensive Cancer Control Program (NCCCP). - Government Buyer: - Centers for Disease Control and Prevention (CDC) - National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) - Office of Public Health Ethics and Regulations, Office of Science - No OEMs or commercial vendors are involved; this is not a procurement for products or services - Services Requested: - Web-based surveys (administered twice to NCCCP recipients, including program coordinators and staff/partners/coalition members) - Annual focus groups (with NCCCP recipients to collect qualitative data) - Total estimated annualized response burden: 96 hours - Unique Requirements: - Evaluation targets 66 NCCCP recipients across states, tribes, and territories - Focus is on assessing the impact of TTA on cancer control efforts and program capacity - Participation is voluntary and no incentives are provided - No products, part numbers, or purchase quantities are listed - The evaluation is part of a three-year project seeking OMB approval for data collection
Description
This notice from the Department of Health and Human Services and the Centers for Disease Control and Prevention announces the review of agency forms under the Paperwork Reduction Act. It pertains to the information collection request titled "Evaluating the Impact of Training and Technical Assistance (TTA) Programs for NCCCP Efforts." The evaluation aims to assess the effectiveness of TTA programs in supporting cancer control efforts across various states and territories. The notice invites public comments on the proposed data collection and provides details on the evaluation design and burden estimates.